Last reviewed · How we verify

NCT05012150: EQuiPP

A Pilot Study in Endoscopic Therapy on Quality of Life and Pain in Chronic Pancreatitis

Active, enrolled Last updated 24 October 2025
What this trial tests

trial in Chronic Pancreatitis in 32 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
5 January 2021
Primary endpoint
30 June 2026
30 December 2026

Quick facts

Lead sponsorOhio State University
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment32
Start date5 January 2021
Primary completion30 June 2026
Estimated completion30 December 2026
Sites1 location across United States

Conditions studied

Sponsor

Ohio State University

Who can join

Adults 18 to 90, any sex, with Chronic Pancreatitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a prospective study designed to assess the effect of pancreatic endotherapy on quality of life, pain levels, pancreatic exocrine function, and endocrine function.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Management of chronic pancreatitis: recent advances and future prospects.
    Han C, Lv YW, Hu LH. · · 2024 · cited 5× · PMID 38406795 · DOI 10.1177/17562848241234480

Verify or expand the search:

Other recruiting trials for Chronic Pancreatitis

Currently open trials in the same condition.

Other Ohio State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05012150.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing